The FDA’s latest draft guidance on accelerated approvals — one step forward, two steps back?
Crossref DOI link: https://doi.org/10.1038/s41571-023-00788-5
Published Online: 2023-05-31
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Benjamin, David J. https://orcid.org/0000-0002-2392-886X
Lythgoe, Mark P. https://orcid.org/0000-0002-8952-7639
Text and Data Mining valid from 2023-05-31
Version of Record valid from 2023-05-31
Article History
First Online: 31 May 2023
Competing interests
: The authors declare no competing interests.